Banker & Tradesman
September 28, 2016
A Cambridge-based pharmaceuticals company has signed a 15-year lease for a 200,000-square-foot drug manufacturing facility at 100 Tech Drive in Norwood.
Moderna Pharmaceuticals is a clinical stage biotech company founded in 2011 that specializes in therapies for infectious diseases, rare diseases, immuno-oncology, cardiovascular disease and pulmonary diseases. Moderna has two Phase 1 human studies underway in the U.S. and Europe for infectious disease vaccines.
Known as Upland, the property is owned by Braintree-based Campanelli and TriGate Capital of Dallas, Texas.
The company will begin initial build-out of the new facility in October 2016 and plans to open the facility by early 2018.
Newmark Grubb Knight Frank’s Mike Frisoli, Taryn Wilson and Matt Morgan represented ownership. Moderna was represented by JLL’s Peter Bekarian, Tom Kent and Don Domoretsky.